A CYP7A1 CYP7A1 1.2 1.2 AICAR (2 mM) 1.0 1.0 0.8 * 0.8 mRNA expression

Slides:



Advertisements
Similar presentations
1. Improving Adenovirus Transduction of ASC Babak Negahdari 2.
Advertisements

Supporting Figure 1: Acute leptin and IL-6 treatments on pY-STAT3 phosphorylation in HuH7 cells. A) HuH7 cells were transfected with pcDNA3-LepRb and empty.
Adipose PancreasAorta MuscleHeart Liver LungKidney Testis Spleen Brian 18S p55 γ p55 α Figure S1 Tissue distribution of p55 . (A) Representative RT-PCR.
Fig.S1. Effects of various inhibitors on LPS-induced TNFα mRNA expression in RAW264.7 cells. The same experimental procedures were performed as described.
Fig. 1. GLP-1 induces miR-132 and miR-212 expression in pancreatic β-cells in vitro and in vivo. (A) MiRNA expression profiling of GLP-1 treated INS-1.
(a)(b) Fig. S1 Figure S1. Functional classification of genes that were upregulated (a) or downregulated (b) by systemic application of GA. Five micro liter.
Volume 131, Issue 1, Pages (July 2006)
Figure 1. WA down-regulates H
a b c ** ** ** ** * * * P450arom mRNA Trascript Levels (Fold)
Fig S1 Mannitol pre-treatment dosen’t affect RANKL-induced macrophage activation. A B To study the effect of mannitol pre-treatment, as a control for osmotic.
Volume 148, Issue 2, Pages e7 (February 2015)
Interferon (IFN)-Induced Protein 35 (IFI35), a Type I Interferon-Dependent Transcript, Upregulates Inflammatory Signaling Pathways by Activating Toll-Like.
Loss of USP8 or HIF1α impairs endocytic recycling required for ciliogenesis Kinetic analysis of transferrin recycling measured by flow cytometry. Loss.
M. -H. Moon, J. -K. Jeong, Y. -J. Lee, J. -W. Seol, C. J. Jackson, S
Effects of cytokines on P450 mRNA expression in human hepatocytes.
Volume 35, Issue 4, Pages (October 2011)
Volume 148, Issue 2, Pages e7 (February 2015)
Volume 13, Issue 4, Pages (April 2011)
(A) ZR75-1 cells were treated with 1 μM 5-aza-2′-deoxycytidine (5-Aza) for 4 d. (A) ZR75-1 cells were treated with 1 μM 5-aza-2′-deoxycytidine (5-Aza)
A B 20% O2 5% O2 C 5% O2 + NAC DAPI gH2AX pLKO.1 GFP-SOD1 S 0.1Gy
Volume 22, Issue 7, Pages (July 2015)
a b MCF-7 TR2 MCF-7 TR2 (Fold change) MTT Assay , (Fold change)
Volume 49, Issue 6, Pages (March 2013)
Supplementary Figure 2. Effect of IL-32 and siRNA of IL-32 on melanoma, colon and prostate cancer cell growth and apoptosis as well as IL-32 expression.
Volume 11, Issue 4, Pages (April 2010)
Volume 130, Issue 3, Pages (September 2013)
Pioglitazone inhibits aromatase expression in human preadipocytes.
Volume 138, Issue 5, Pages e2 (May 2010)
Deubiquitination and Activation of AMPK by USP10
Volume 18, Issue 3, Pages (April 2005)
Suppression of Sestrins in aging and osteoarthritic cartilage: dysfunction of an important stress defense mechanism  T. Shen, O. Alvarez-Garcia, Y. Li,
Supplementary Figure 1 HCT116 MOLT4
Volume 40, Issue 1, Pages (January 2014)
Volume 14, Issue 5, Pages (May 2008)
Fold Change of hsa-miR-3687 (T/N)(log2)
A Novel Role of Transforming Growth Factor β1 in Transcriptional Repression of Human Cholesterol 7α-Hydroxylase Gene  Tiangang Li, John Y.L. Chiang  Gastroenterology 
E7-less STING isoforms are proviral replication factors.
Volume 18, Issue 4, Pages (October 2013)
Volume 12, Issue 4, Pages (July 2015)
Supplementary Fig. S1 BCL2 5’flanking ctrl siRNA luc
Volume 50, Issue 2, Pages (April 2013)
Volume 21, Issue 4, Pages e4 (April 2017)
AMPK induces VEGF-A production by upregulating ERK signaling.
Supplemental Figure 4 A no agonist MALP2 PAM3CSK4 GFP WT F217S
PAS Kinase Drives Lipogenesis through SREBP-1 Maturation
Suppression of Oncolytic Adenovirus-Mediated Hepatotoxicity by Liver-Specific Inhibition of NF-κB  Mitsuhiro Machitani, Fuminori Sakurai, Keisaku Wakabayashi,
Supplementary Figure 1 A B C SW620 HT29 SW620
Xiaoyue Pan, Yuxia Zhang, Li Wang, M. Mahmood Hussain  Cell Metabolism 
MAPK14 regulates ROS generation in GS cells.
STAT5a/PPARγ Pathway Regulates Involucrin Expression in Keratinocyte Differentiation  Xiuju Dai, Koji Sayama, Yuji Shirakata, Yasushi Hanakawa, Kenshi.
Identification of Z-FA-FMK as a potent compound that increases SMN protein expression in HEK293 and patient fibroblast cells. Identification of Z-FA-FMK.
Effect of insulin on hepcidin expression in HepG2 cells.
BTG2-mediated hepatic gluconeogenesis is mediated by Nur77.
Allopurinol up-regulates DR5 expression in PC-3 and DU145 cells.
Functional analysis of Mapk14 in SSCs by spermatogonial transplantation. Functional analysis of Mapk14 in SSCs by spermatogonial transplantation. (A) Macroscopic.
ROS generation and enhanced proliferation of GS cells by Nox1 transfection. ROS generation and enhanced proliferation of GS cells by Nox1 transfection.
Involvement of PKCα in downregulation of GLP-1 receptor by high glucose in isolated rat islets. Involvement of PKCα in downregulation of GLP-1 receptor.
Fig. 1. Stomatin expression in 3T3-L1 adipocytes
Volume 11, Issue 3, Pages (March 2010)
Induction of CDCP1 is regulated by Ras in NSCLC cells.
Competition between FLYWCH1/β-catenin and TCF4/β-catenin complexes for their interaction to Tcf-DNA-binding sites. Competition between FLYWCH1/β-catenin.
Volume 125, Issue 2, Pages (August 2003)
A, expression of p53 downstream mediator p21.
Fig. 1 Dcr-2 is required for Toll signaling in Drosophila S2 cells.
Fig. 4 Dcr-2 binds to the 3′UTR of Toll mRNA.
scrambled si-CLOCK scrambled si-CLOCK scrambled si-CLOCK scrambled
Hcy decreases VEGFR1/2 and Angs (Ang1, Ang2) gene transcription
PARP1 suppresses the transcription of PD-L1 in cancer cells.
BRAF-mutant melanoma cells are resistant to the antigrowth effects of metformin and AICAR in vitro. BRAF-mutant melanoma cells are resistant to the antigrowth.
Volume 9, Issue 2, Pages (October 2014)
Presentation transcript:

A CYP7A1 CYP7A1 1.2 1.2 AICAR (2 mM) 1.0 1.0 0.8 * 0.8 mRNA expression 0.6 mRNA expression * 0.6 0.4 0.4 * * 0.2 0.2 AICAR (mM) - 1 2 0h 2h 6h 24h B CYP27A1 CYP27A1 1.2 1.4 AICAR (2 mM) 1.0 1.2 1.0 0.8 0.8 mRNA expression 0.6 mRNA expression 0.6 0.4 0.4 0.2 0.2 AICAR (mM) - 1 2 0h 2h 6h 24h C. HNF4 HNF4 1.2 1.4 1.2 1.0 1.0 0.8 mRNA expression 0.8 mRNA expression 0.6 0.6 0.4 0.4 0.2 0.2 AdGFP AdAMPKα2 Ad DN-AMPK AICAR(mM) - 1 2 Supplemental Fig 1. HepG2 cells were treated with AICAR for time periods and doses indicated, or infected with Ad-GFP, Ad-AMPKα2 or Ad-DN-AMPK at an MOI of ~ 10 for 24 hr. mRNA expressions were determined by real-time PCR in triplicates and expressed as mean ± S.D.

ChREBP mRNA expression Sicon siACL siAceCS1 5.5 mM 27.7 mM ChREBP 1 2 3 4 5 6 * Supplemental Fig 2. HepG2 cells were transfected with siCon, siACL or siAceCS1 and treated with 5.5 or 27.5 mM glucose for 24 hr as described in Materials and Methods. The mRNA expression levels were determined by real-time PCR.